GENE:MAP2K2
GeneInfo:
GeneAttribute | GeneDescription |
---|---|
GeneSymbol | MAP2K2 |
FullNmae | mitogen-activated protein kinase kinase 2 |
LocusType | gene with protein product |
Status | Approved |
HGNC_id | HGNC:6842 |
EnsembleID | ENSG00000126934 |
Uniprot | P36507 |
Protein Structure:
Gene Description in Publicaton:
GeneSymbol | CellDeathType | PMID | Description | GeneType |
---|---|---|---|---|
MAP2K2 | necroptosis | 38538696 | The 18 RCD signatures collected from previous studies. Supplementary Table of Figures.xlsx (https://github.com/zwxiangya/RCDscore) | retulator signature |
MAP2K2 | immunogenic | 38538696 | The 18 RCD signatures collected from previous studies. Supplementary Table of Figures.xlsx (https://github.com/zwxiangya/RCDscore) | retulator signature |
MAP2K2 | apoptosis | 38538696 | The 18 RCD signatures collected from previous studies. Supplementary Table of Figures.xlsx (https://github.com/zwxiangya/RCDscore) | retulator signature |
MAP2K2 | cuproptosis | 38495196 | Cuproptosis-related genes were manually curated, and differentially expressed cuproptosis-related genes (DECuGs) were identified.Then, the 16 DECuGs were obtained by the intersection of the 5018 DEGs and 63 cuproptosis-related genes. | 63 cuproptosis-related genes |
MAP2K2 | cuproptosis | 38348451 | Components of the MAPK signaling pathway. MAPK pathways can be activated in response to stress and may contribute to cell death mechanisms. | CRGs in the cuproptosis pathway |
MAP2K2 | cuproptosis | 36211378 | Forty-three cuproptosis-related genes were selected from the review of Chang et al. (13) | 43 cuproptosis-related genes in the study |
MAP2K2 | cuproptosis | 36568423 | Additionally, 41 cuproptosis regulators were obtained from the previous publications. | cuproptosis-related genes |
Go Annotation:
GeneSymbol | Go id |
---|---|
MAP2K2 | GO:0000165,GO:0004674,GO:0004708,GO:0004708,GO:0004712,GO:0004713,GO:0005078,GO:0005515,GO:0005524,GO:0005576,GO:0005634,GO:0005739,GO:0005769,GO:0005770,GO:0005778,GO:0005783,GO:0005794,GO:0005794,GO:0005829,GO:0005874,GO:0005911,GO:0005925,GO:0007507,GO:0009898,GO:0010628,GO:0030165,GO:0030878,GO:0032872,GO:0036289,GO:0043410,GO:0043539,GO:0045893,GO:0046872,GO:0048009,GO:0048471,GO:0048538,GO:0048679,GO:0050772,GO:0060324,GO:0060440,GO:0060502,GO:0070371,GO:0070371,GO:0071902,GO:0090170,GO:0097110,GO:0106310,GO:2000147,GO:2000641 |
KEGG Annotation:
GeneSymbol | GeneID | Pathway | Pathway Name |
---|---|---|---|
MAP2K2 | hsa:5605 | path:hsa01521 | EGFR tyrosine kinase inhibitor resistance - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa01522 | Endocrine resistance - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04010 | MAPK signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04012 | ErbB signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04014 | Ras signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04015 | Rap1 signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04022 | cGMP-PKG signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04024 | cAMP signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04066 | HIF-1 signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04068 | FoxO signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04071 | Sphingolipid signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04072 | Phospholipase D signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04140 | Autophagy - animal - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04148 | Efferocytosis - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04150 | mTOR signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04151 | PI3K-Akt signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04210 | Apoptosis - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04218 | Cellular senescence - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04270 | Vascular smooth muscle contraction - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04370 | VEGF signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04371 | Apelin signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04540 | Gap junction - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04550 | Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04613 | Neutrophil extracellular trap formation - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04620 | Toll-like receptor signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04650 | Natural killer cell mediated cytotoxicity - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04660 | T cell receptor signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04662 | B cell receptor signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04664 | Fc epsilon RI signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04720 | Long-term potentiation - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04722 | Neurotrophin signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04730 | Long-term depression - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04810 | Regulation of actin cytoskeleton - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04910 | Insulin signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04912 | GnRH signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04915 | Estrogen signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04916 | Melanogenesis - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04917 | Prolactin signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04919 | Thyroid hormone signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04921 | Oxytocin signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04926 | Relaxin signaling pathway - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04929 | GnRH secretion - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04934 | Cushing syndrome - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa04935 | Growth hormone synthesis, secretion and action - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05010 | Alzheimer disease - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05022 | Pathways of neurodegeneration - multiple diseases - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05132 | Salmonella infection - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05135 | Yersinia infection - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05160 | Hepatitis C - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05161 | Hepatitis B - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05163 | Human cytomegalovirus infection - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05164 | Influenza A - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05165 | Human papillomavirus infection - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05166 | Human T-cell leukemia virus 1 infection - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05167 | Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05170 | Human immunodeficiency virus 1 infection - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05200 | Pathways in cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05205 | Proteoglycans in cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05206 | MicroRNAs in cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05207 | Chemical carcinogenesis - receptor activation - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05208 | Chemical carcinogenesis - reactive oxygen species - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05210 | Colorectal cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05211 | Renal cell carcinoma - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05213 | Endometrial cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05214 | Glioma - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05215 | Prostate cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05216 | Thyroid cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05218 | Melanoma - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05219 | Bladder cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05220 | Chronic myeloid leukemia - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05221 | Acute myeloid leukemia - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05223 | Non-small cell lung cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05224 | Breast cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05225 | Hepatocellular carcinoma - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05226 | Gastric cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05230 | Central carbon metabolism in cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05231 | Choline metabolism in cancer - Homo sapiens (human) |
MAP2K2 | hsa:5605 | path:hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer - Homo sapiens (human) |
Protein-Protein Interaction(String):
Gene-Drug Network:
Signalink 3.0 modificators
Source | Target | Pmid | Interactiontype | Methods | Database |
---|---|---|---|---|---|
MAP2K2 | MAPK3 | 11134045 11242034 18988627 21071413 23180781 23331499 7687743 8226933 8626767 | stimulation,physical association | pull down | InnateDB,SignaLink,SignaLink |
MAP2K2 | EGR1 | 19374776 23180781 | physical association | anti tag coimmunoprecipitation | InnateDB |
MAP2K2 | MAPK1 | 11134045 11823456 16293107 18988627 23331499 | stimulation | N/A | SignaLink,SignaLink |
MAPK1 | MAP2K2 | 11823456 21071413 23331499 9922370 | interaction type | N/A | SignaLink,SignaLink |
BRAF | MAP2K2 | 23331499 8668348 | stimulation | N/A | SignaLink,SignaLink |
RAF1 | MAP2K2 | 16293107 18988627 23331499 8157000 8393135 9671314 9808624 | stimulation | N/A | SignaLink,SignaLink |
MAP3K7 | MAP2K2 | 13130464 23109003 8177321 9851932 | chemical activation reaction | N/A | SignaLink |
MAP2K7 | MAP2K2 | 23109003 7997270 | chemical activation reaction | N/A | SignaLink |
MAP3K1 | MAP2K2 | 15032589 23109003 | chemical activation reaction | N/A | SignaLink |
Source | Target | Pmid | Interactiontype | Methods | Database |
---|---|---|---|---|---|
AR | MAP2K2 | 20610535 | trascriptional regulation,stimulation | chromatin immunoprecipitation array | TFlink |
ETS1 | MAP2K2 | 18971253 20019798 | trascriptional regulation,stimulation | inferred by curator,chromatin immunoprecipitation assay | TFlink |
GATA1 | MAP2K2 | 19941826 | trascriptional regulation,stimulation | chromatin immunoprecipitation assay | TFlink |
GATA2 | MAP2K2 | 19941826 | trascriptional regulation,stimulation | chromatin immunoprecipitation assay | TFlink |
FOXP3 | MAP2K2 | 20554955 | trascriptional regulation,stimulation | chromatin immunoprecipitation array | TFlink |
SMARCA4 | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
CEBPA | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
EGR1 | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
FOXA1 | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
FOS | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
MITF | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
RUNX1 | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
SPI1 | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
TP53 | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
ZNF263 | MAP2K2 | 18971253 | trascriptional regulation,stimulation | inferred by curator | TFlink |
Source | Target | Pmid | Interactiontype | Methods | Database |
---|---|---|---|---|---|
URS0000324096 | MAP2K2 | 18668040 25416803 | mrna cleavage,inhibition | experimental interaction detection | TarBase |
URS000042935A | MAP2K2 | 22012620 25416803 | mrna cleavage,inhibition | clip | TarBase |
URS00000AA464 | MAP2K2 | 22012620 25416803 | mrna cleavage,inhibition | clip | TarBase |
URS000052E1A6 | MAP2K2 | 22012620 25416803 | mrna cleavage,inhibition | clip | TarBase |
URS00004900F1 | MAP2K2 | 22012620 25416803 | mrna cleavage,inhibition | clip | TarBase |
URS0000209F04 | MAP2K2 | 23824327 25416803 | mrna cleavage,inhibition | clip | TarBase |
URS0000184017 | MAP2K2 | 23824327 25416803 | mrna cleavage,inhibition | clip | TarBase |
URS00001C3AC1 | MAP2K2 | 25416803 27418678 | mrna cleavage,inhibition | clip | TarBase |
URS00001A122A | MAP2K2 | 25416803 27418678 | mrna cleavage,inhibition | clip | TarBase |
Source | Target | Pmid | Interactiontype | Methods | Database |
---|---|---|---|---|---|
CHEK1 | MAP2K2 | 22135298 | phosphorylation | N/A | PhosphoSite |
PDPK1 | MAP2K2 | 22135298 | phosphorylation | N/A | PhosphoSite |
PLK1 | MAP2K2 | 22135298 | phosphorylation | N/A | PhosphoSite |
MAP2K2 | MAPK3 | 22135298 | phosphorylation | N/A | PhosphoSite |
MAP2K2 | KRT8 | 22135298 | phosphorylation | N/A | PhosphoSite |
MAP3K8 | MAP2K2 | 22135298 | phosphorylation | N/A | PhosphoSite |
BRAF | MAP2K2 | 22135298 | phosphorylation | N/A | PhosphoSite |
Source | Target | Pmid | Interactiontype | Methods | Database |
---|---|---|---|---|---|
HNRNPK | MAP2K2 | 25348397 | N/A | two hybrid | ComPPI |
MOS | MAP2K2 | 24234451 25348397 | physical association | two hybrid,two hybrid array,two hybrid prey pooling approach | ComPPI,IntAct |
SNW1 | MAP2K2 | 20467437 24234451 25348397 | association | anti bait coimmunoprecipitation,physical interaction | ComPPI,IntAct |
HSPA8 | MAP2K2 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | MAPK1 | 11134045 11823456 14525934 25348397 | N/A | two hybrid,experimental interaction detection,physical interaction,in vitro,in vivo,two hybrid | ComPPI,HPRD |
MAP2K2 | ARAF | 11909642 14525934 21988832 24234451 24746704 25348397 25852190 | association,physical association | anti tag coimmunoprecipitation,two hybrid,experimental interaction detection,pull down,physical interaction,in vitro,two hybrid | ComPPI,HPRD,IntAct |
MAP2K2 | DUSP3 | 10224087 14525934 25348397 | N/A | experimental interaction detection,in vitro,in vivo | ComPPI,HPRD |
MAP2K2 | MAPK3 | 14525934 25348397 7687743 8226933 8626767 | N/A | experimental interaction detection,physical interaction,in vitro | ComPPI,HPRD |
MAP2K2 | CASP9 | 12792650 14525934 25348397 | N/A | experimental interaction detection,in vitro,in vivo | ComPPI,HPRD |
MAP2K2 | GRIN2D | 10862698 14525934 25348397 | N/A | experimental interaction detection,in vivo | ComPPI,HPRD |
MAP2K2 | LAMTOR3 | 14525934 25348397 9733512 | N/A | experimental interaction detection,in vitro | ComPPI,HPRD |
MAP2K2 | GRIN1 | 10862698 14525934 25348397 | N/A | experimental interaction detection,in vivo | ComPPI,HPRD |
MAP2K2 | RAF1 | 11909642 14525934 21988832 24234451 24746704 25348397 8157000 8393135 9671314 9808624 | association,physical association | anti tag coimmunoprecipitation,two hybrid,experimental interaction detection,physical interaction,in vitro,in vivo | ComPPI,HPRD,IntAct |
MAP2K2 | RGS12 | 14525934 17380122 25348397 | N/A | two hybrid,experimental interaction detection,in vivo,two hybrid | ComPPI,HPRD |
MAP2K2 | BRAF | 14525934 17979178 24234451 24746704 25348397 25600339 8668348 | association,physical association | anti bait coimmunoprecipitation,anti tag coimmunoprecipitation,experimental interaction detection,physical interaction,in vitro,tandem affinity purification | ComPPI,HPRD,IntAct |
MAP2K2 | MEPCE | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | COPS5 | 18624398 20936779 24234451 25348397 | physical association | two hybrid,physical interaction,two hybrid pooling approach | ComPPI,IntAct |
MAP2K2 | YWHAB | 24234451 24255178 25348397 | association | anti tag coimmunoprecipitation,physical interaction | ComPPI,IntAct |
MAP2K2 | MAP2K1 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | WDR83 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | MAPK8 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | LIG4 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | PEX14 | 21525035 24234451 25348397 | association | pull down,physical interaction | ComPPI,IntAct |
MAP2K2 | ZNF207 | 21988832 24234451 25348397 | physical association | two hybrid,physical interaction | ComPPI,IntAct |
MAP2K2 | RIPOR2 | 21988832 24234451 25348397 | physical association | two hybrid,physical interaction | ComPPI,IntAct |
MAP2K2 | IQGAP1 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | NFE2L2 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | EGFR | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | CCNDBP1 | 24234451 25348397 25416956 | physical association | physical interaction,two hybrid array,two hybrid prey pooling approach,validated two hybrid | ComPPI,IntAct |
MAP2K2 | ART3 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | ACTL6A | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | TNF | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | PDLIM5 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | RPE | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | TXN | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | XPO1 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | SERPINB2 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | TUBA4A | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | CD70 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | NOCT | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | DLD | 24234451 25348397 29128334 | association | cross-linking study,physical interaction | ComPPI,IntAct |
MAP2K2 | TRIM25 | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | HNRNPL | 25348397 | N/A | physical interaction | ComPPI |
MAP2K2 | MCC | 17353931 24234451 25348397 | physical association | anti bait coimmunoprecipitation | ComPPI,IntAct |
MAP2K2 | KSR1 | 11909642 24234451 25348397 27086506 | association,physical association | anti tag coimmunoprecipitation,two hybrid | ComPPI,IntAct |
MAP2K2 | DLG1 | 21615688 24234451 25348397 27898060 | colocalization,physical association | anti bait coimmunoprecipitation,two hybrid,fluorescence microscopy | ComPPI,IntAct,OmniPath |
MAP2K2 | PKM | 25348397 | N/A | protein kinase assay | ComPPI |
MAP2K2 | HSCB | 24234451 25348397 28380382 | association | anti bait coimmunoprecipitation | ComPPI,IntAct |
MAP2K2 | KSR2 | 24234451 25348397 27086506 | association | anti tag coimmunoprecipitation | ComPPI,IntAct |
MAP2K2 | MAP2K2 | 11909642 14525934 17192257 24234451 8226933 | physical association | two hybrid,experimental interaction detection | HPRD,IntAct |
MAP3K8 | MAP2K2 | 12506122 12609978 15466476 17101779 17906627 18187448 27898060 | stimulant | N/A | OmniPath |
MAP2K2 | KRT8 | 10623656 11781324 11788583 15368451 15707998 15763073 15972820 16343483 16554440 17535969 18617517 19115206 19246484 19796649 20663917 20724476 22114688 23358244 25963979 27898060 9211903 | N/A | N/A | OmniPath |
MAP2K2 | CASP9 | 12792650 18669648 27898060 | N/A | N/A | OmniPath |
BRAF | MAP2K2 | 18039929 25600339 27898060 8668348 | stimulant | N/A | OmniPath |
PDPK1 | MAP2K2 | 15175348 27898060 | stimulant | N/A | OmniPath |
MAP2K2 | MAPK6 | 18039929 27898060 | stimulant | N/A | OmniPath |
MAP2K2 | MAPK3 | 11134045 11242034 11251083 1411546 15580310 15951569 16497976 16887817 17081983 17192257 17389395 17906627 18083107 18669648 18691976 18707149 18983981 19369195 19494114 19534553 19651622 19690332 19901323 20068231 27898060 7687743 8226933 8626767 9006895 | stimulant | N/A | OmniPath |
RAF1 | MAP2K2 | 11909642 16293107 16364241 17116858 18039929 18669648 19058874 19369195 21988832 27898060 8157000 8393135 9671314 9808624 | stimulant | N/A | OmniPath |
MAPK1 | MAP2K2 | 11134045 11823456 12788955 16293107 21675959 27898060 9922370 | stimulant | N/A | OmniPath |
MAP2K2 | MAPK1 | 11134045 11823456 11971971 12788955 15592455 15951569 16094384 16293107 17081983 17192257 17389395 17906627 18039929 18083107 18669648 18691976 19053285 19369195 19494114 19534553 19690332 21675959 27898060 9922370 | stimulant | N/A | OmniPath |
MAP2K2 | PPARG | 18596912 27898060 | stimulant | N/A | OmniPath |
PPP2CA | MAP2K2 | 20626350 27898060 | inhibition | N/A | OmniPath |
ARAF | MAP2K2 | 11909642 18039929 21779497 21988832 25852190 27898060 | stimulant | N/A | OmniPath |
DUSP3 | MAP2K2 | 10224087 27898060 | N/A | N/A | OmniPath |